Iroko Pharmaceuticals to Present at Oppenheimer 24th Annual Healthcare Conference

PHILADELPHIA, DECEMBER 5, 2013 — Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company will be presenting at the Oppenheimer & Co. 24th Annual Healthcare Conference, taking place at the Crowne Plaza Hotel in New York.  Iroko’s President and CEO, John Vavricka, will present on December 11, 2013, at 1:00 p.m. Eastern Time.

About Iroko Pharmaceuticals, LLC

Iroko is a global specialty pharmaceutical company, based in Philadelphia, dedicated to advancing the science of analgesia. The company develops and globally commercializes pharmaceutical products. In addition to the Iroko products that are marketed worldwide, the company has a robust pipeline of investigational lower dose NSAID products being developed using iCeutica Pty Ltd’s proprietary SoluMatrix Fine Particle Technology™.  For more information, visit www.iroko.com.

Contacts:

Jessica Donnelly for Iroko Pharmaceuticals, LLC, 212-798-9819

Kate de Santis, Iroko Pharmaceuticals, LLC, 267-546-1682

SoluMatrix Fine Particle Technology™ is a trademark of iCeutica Pty Ltd, and is licensed to Iroko for exclusive use in NSAIDs.

###